ExploreWatchlistsPricing
  1. JP-listed companies
  2. MEDIPAL HOLDINGS CORPORATION
  3. Financials
  4. Net income

MEDIPAL HOLDINGS CORPORATION (7459)

Market cap
¥626.9B
P/E ratio
17.1x
Medipal Holdings distributes pharmaceuticals, medical devices, cosmetics, daily necessities, and veterinary products through 34 subsidiaries across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202551,530-0.46%
Mar 31, 202451,768+7.13%
Mar 31, 202348,323+23.29%
Mar 31, 202239,196+16.60%
Mar 31, 202133,616-34.38%
Mar 31, 202051,229+12.78%
Mar 31, 201945,425+4.34%
Mar 31, 201843,536+19.81%
Mar 31, 201736,338-1.58%
Mar 31, 201636,922+26.88%
Mar 31, 201529,100+284.16%
Mar 31, 20147,575-33.08%
Mar 31, 201311,320+99.58%
Mar 31, 20125,672

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat